Cargando…
Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019
IMPORTANCE: Older age may be accompanied by changes in the pharmacokinetics or pharmacodynamics or both of medications that can result in altered safety and efficacy profiles. OBJECTIVE: To assess representation of older adults in clinical trials of new drug applications (NDAs) and biologics license...
Autores principales: | Lau, S. W. Johnny, Huang, Yue, Hsieh, Julie, Wang, Shenggang, Liu, Qi, Slattum, Patricia W., Schwartz, Janice B., Huang, Shiew-Mei, Temple, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568796/ https://www.ncbi.nlm.nih.gov/pubmed/36239939 http://dx.doi.org/10.1001/jamanetworkopen.2022.36149 |
Ejemplares similares
-
Product Licenses Database Application
por: Tonkovikj, Petar
Publicado: (2016) -
Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by Applicants
por: Chahal, Harinder Singh, et al.
Publicado: (2021) -
The Association between Sleep Problems, Sleep Medication Use, and Falls in Community-Dwelling Older Adults: Results from the Health and Retirement Study 2010
por: Min, Yaena, et al.
Publicado: (2016) -
Licensing Examination and Crash Outcomes Postlicensure in Young Drivers
por: Walshe, Elizabeth A., et al.
Publicado: (2022) -
Domains of professional practice: analysis of publications in the Journal of the Medical Library Association from 2010 to 2019
por: Thompson, Holly J., et al.
Publicado: (2023)